Certified by Founder Lodge
Avidity Partners
United States - ND
INVESTOR
1 Disclosed Funding Rounds $50,000,000
12 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Avidity Private Fund I is a buyout fund managed by Avidity Partners. The fund is located in Dallas, Texas.
| Company | Date | Round | Raised |
|---|---|---|---|
 858 Therapeutics |
September, 27 ,2024 | Series B | $50,000,000 |
 Quanta Therapeutics |
May, 23 ,2023 | Series D | $50,000,000 |
 Sirona Medical |
November, 27 ,2024 | Series C | $42,000,000 |
 Octave |
June, 16 ,2023 | Series C | $52,000,000 |
 Affinia Therapeutics |
October, 10 ,2025 | Series C | $40,000,000 |
 MBrace Therapeutics |
November, 15 ,2023 | Series B | $85,000,000 |
 Artios |
November, 18 ,2025 | Series D | $115,000,000 |
 Calyxo, Inc. |
December, 13 ,2023 | Series D | $50,000,000 |
| 858 Therapeutics |
September, 27 ,2024 | Series B | $50,000,000 |
| Sirona Medical |
November, 27 ,2024 | Series C | $42,000,000 |
| Affinia Therapeutics |
October, 10 ,2025 | Series C | $40,000,000 |
| Artios |
November, 18 ,2025 | Series D | $115,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Govstream.ai | $3,600,000 | (Dec 5, 2025)
ZincFive, Inc. | $30,000,000 | (Dec 5, 2025)
imper.ai | $28,000,000 | (Dec 5, 2025)
SPhotonix Inc | $4,500,000 | (Dec 5, 2025)
Multifactor (YC F25) | $15,000,000 | (Dec 5, 2025)
